Taylor Ballew
Psychiatric/Mental Health · Morganton, NCNPI 1093272759
Payments from drug & device makers
What this record shows
This record is dominated by other: $5,419 of the $7,182 with a category attached, or 75.5%. Neuronetics, Inc. accounts for 75.5% of it on its own, with 14 other manufacturers making up the rest. Among psychiatric/mental health clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 96 payments — averaging $74.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neuronetics, Inc.$5K
- AbbVie$904
- Otsuka America Pharmaceutical, Inc.$242
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$138
- Teva Pharmaceuticals USA, Inc.$109
- Johnson & Johnson$80
- plus $290 from 9 others
What the payments were for
- Food & beverage$1,76325%
- Other$5,41975%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neuronetics, Inc. | 2 | $5,419 |
| AbbVie | 56 | $904 |
| Otsuka America Pharmaceutical, Inc. | 7 | $242 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $138 |
| Teva Pharmaceuticals USA, Inc. | 6 | $109 |
| Johnson & Johnson | 3 | $80 |
| Ironshore Pharmaceuticals Inc. | 2 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $47 |
| Corium, LLC | 2 | $47 |
| Lundbeck LLC | 3 | $47 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $25 |
| Alkermes, Inc. | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
| Tris Pharma Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEUROSTAR TMS THERAPY SYSTEM$5,419
- REXULTI$125
- VRAYLAR$119
How this compares
$7,182 in reported general payments places this provider in the 90th percentile of 947 psychiatric/mental health providers in North Carolina.
See all psychiatric/mental health providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 29 | $1,673 |
| Lurasidone Hcl | 18 | $593 |
| Buspirone Hcl | 16 | $245 |
| Hydroxyzine Hcl | 13 | $142 |
| Lamotrigine | 12 | $83 |
| Eszopiclone | 13 | $52 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Morganton
- Desiree MatthewsCharlotte$807K
- Benedetto PalomboCharlotte$671K
- Clarence RunnelsCreedmoor$339K
- Lisa SuddrethGastonia$111K
- April NandigamGreensboro$88K
- Hannah NealeyFuquay Varina$75K
- Jessica StoneRocky Mount$63K
- Deborah GranickRaleigh$28K
- Ronald PattersonFayetteville$25K
- Ajay PatelRaleigh$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.